The initial public offering (IPO) calendar for this week lists five companies with plans to enter the public markets. Last week six IPOs were priced, three were postponed and one will try again this week.

Through the week ending August 7, IPO ETF manager Renaissance Capital reported that 127 IPOs have priced in the United States so far this year, down about 32% from a year ago. Total proceeds raised through last week equaled $21.9 billion, down about 46% compared with the same period in 2014. Of the 127 IPOs that have gone off this year, 56 have come from the health care sector. Last year’s IPO total came in at $85.2 billion, the highest total in the past 10 years. Renaissance Capital does not include “best efforts” or blank check companies in its totals.

Last week’s largest one-day pop was posted by Aimmune Therapeutics Inc. (NASDAQ: AIMT), which gained 51% on its first day of trading and finished the week up 44%. Zynerba Pharmaceuticals Inc. (NASDAQ: ZYNE) closed on Friday up 75%. Planet Fitness Inc. (NYSE: PLNT) rose 14% on two days of trading, after a rocky start on Thursday.

Of the five firms lined up to price and begin trading in the coming week, we have two health care offerings, a bank holding company, an investment bank and an educational technology firm.

ALSO READ: Recent IPOs Running Out of Cash

Returning for another try this week is GC Aesthetics PLC, an Ireland-based pure-play female aesthetics company. The company plans to offer 5.4 million shares in an IPO price range of $13 to $15 to raise about $75 million at an implied market cap of $242.2 million. Joint bookrunners for the offering are Bank of America Merrill Lynch, Deutsche Bank and Cowen. Co-manager is William Blair. Shares are listed as day-to-day and are set to trade on the Nasdaq under the ticker symbol GCAA.

Conifer Holdings Inc. is a Michigan-based bank holding company. It plans to offer 4.6 million shares in an expected price range of $11 to $13 to raise about $55 million at an implied market cap of around $107 million. Joint bookrunners for the offering are BMO Capital Markets and Raymond James. Co-managers are Sandler O’Neill and William Blair. Shares are scheduled to price on Tuesday and begin trading Wednesday on the Nasdaq under the ticker symbol CNFR.

Global Blood Therapeutics Inc. is a biopharmaceutical company working to discover, develop and commercialize novel therapeutics to treat grievous blood-based disorders. Its first product candidate is a prophylactic treatment for sickle cell disease. The company plans to offer 6 million shares in an IPO price range of $16 to $18, raising $102 million at an implied market cap of about $473 million. Joint bookrunners for the offering are Morgan Stanley and Goldman Sachs. Co-managers are Cowen and Wedbush PacGrow. Shares are scheduled to price Tuesday and begin trading Wednesday on the Nasdaq under the ticker symbol GBT.

Houlihan Lokey Inc. is a global independent investment bank with expertise in M&A, financings, financial restructurings and financial advisory services. The company plans to offer 13.1 million shares in an expected price range of $22 to $24 to raise about $300 million at an implied market cap of $1.5 billion. Joint bookrunners include Merrill Lynch, Goldman Sachs, UBS Investment Bank, Keefe Bruyette Woods and Houlihan Lokey. Co-managers are Sandler O’Neill and JMP Securities. Shares are expected to price Wednesday and begin trading Thursday on the New York Stock Exchange under the ticker symbol HLI.

ALSO READ: 6 Analyst Stock Picks Called to Rise 50% to 100%

Boxlight Corp. is a technology company primarily focused on the education and learning industry. The company plans to offer 1.8 million shares in an expected price range of $10 to $12 to raise $20 million at an implied market cap of $87.8 million. Sole bookrunner for the offering is Aegis Capital Corp. Shares are expected to price Thursday and begin trading Friday on the Nasdaq under the ticker symbol BOXL.

Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.